Of the 18.1 million people who will be diagnosed with cancer this year, half will be diagnosed late.¹http://gco.iarc.fr/today/fact-sheets-cancers²https://seer.cancer.gov/ And here’s the really alarming news: patients who detect cancer late are much less likely to survive than those who find it early. We need to rethink the way we approach cancer screening.

We’ve created a completely new way to screen for cancer.

Together with the most prominent medical experts in the nation, we’ve designed proprietary MRI scanning protocols tailored to detect cancer anywhere in the body. Furthermore, every single Ezra scan is analyzed by multiple board-certified radiologists.

In addition to our board-certified radiologists, we’re also developing the Ezra AI — artificial intelligence technology designed to make radiologists more accurate and more productive. The Ezra AI is an investigational device that has not received marketing authorization from the FDA, thus the safety and effectiveness of the device have not yet been established. After further study of our AI technology, we plan to seek FDA clearance and make the Ezra AI available to radiologists.